– USA, TX – Apollo Endosurgery, Inc. (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that John Barr has been appointed to Apollo’s Board of Directors as an independent director, effective immediately.
Mr. Barr will join 9 other directors, a majority of whom are independent under the rules and regulations of the United States Securities and Exchange Commission, and will serve as a member of the Audit and Nominating and Governance Committees.
“John is a highly accomplished leader in the medical device field and an experienced board member who brings a wealth of executive leadership skills and experience to our board,” said Rich Meelia, Chairman of Apollo’s Board of Directors. “We are confident that he will add great value to our Board of Directors and that Apollo will benefit from his insights, judgment and counsel.”
About John Barr
Mr. Barr began his current role as an operating partner with Altamont Capital Partners in January of 2018. He previously served as CEO and a member of the Board of Surgical Specialties Corporation from 2014 through 2017 and, prior to that, held a number of CEO and Executive leadership positions during a career spanning more than 35 years, in healthcare. Mr. Barr holds a masters degree in finance, accounting, and economics from the J.L. Kellogg Graduate School of Management-Northwestern University, and an undergraduate degree in bioengineering from the University of Pennsylvania.
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products are offered in over 70 countries today and include the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the ORBERA Intragastric Balloon.
For more information : http://www.apolloendo.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
